Replies to post #204872 on Biotech Values

[DewDiligence]

PPHM—A tenfold gain in the share price (what you posited) based on post-hoc biomarker data from a trial that was halted for futility would be an astonishing development. The colossal cash ball from outer space (#msg-125278503) is more likely, IMO.